Aydin Caglayan

Medway NHS Foundation Trust

Papers

1

Total Citations

6

H-Index

1

About

Dr. Aydin Caglayan is a dedicated urologic oncologist whose research focuses on the rare and clinically challenging intersection of renal cell carcinoma (RCC) and pregnancy. His work addresses the diagnostic and management complexities of gestational RCC, a condition where tumor symptoms often mimic the physiological changes of pregnancy, leading to delayed detection. In his highly cited 2023 update on the topic, Dr. Caglayan provides a critical synthesis of the literature, offering guidance on imaging, surgical timing, and maternal-fetal outcomes. This contribution has become a key reference for clinicians navigating these difficult cases, accumulating 6 citations in a short period. Beyond this, Dr. Caglayan’s broader research portfolio explores oncologic outcomes in kidney cancer, with a particular emphasis on balancing aggressive treatment with quality of life. His work is distinguished by its practical, patient-centered approach, helping to shape protocols for managing malignancies during gestation. For students and researchers, Dr. Caglayan exemplifies how focused scholarship on a niche clinical problem can have an outsized impact on patient care and clinical decision-making.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Gestational Renal Cell Cancer – An Update
6 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Medway NHS Foundation Trust

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago